Imax price target raised to $27 from $25 at B. Riley

B. Riley analyst Eric Wold raised the firm’s price target on Imax to $27 from $25 and keeps a Buy rating on the shares post the Q1 beat. With demonstrated sustainable post-pandemic box office share gains and strong system installation visibility, the core Imax story remains undervalued at current levels, the analyst tells investors in a research note.